These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25929612)

  • 1. Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study.
    Kobayashi C; Hanadate T; Niwa T; Yoshiyasu T; So M; Matsui K
    J Pediatr Hematol Oncol; 2015 Jul; 37(5):e285-91. PubMed ID: 25929612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of micafungin for prophylaxis against invasive fungal infections in Japanese patients undergoing hematopoietic stem cell transplantation: Results of a post-marketing surveillance study.
    Kobayashi C; Hanadate T; Niwa T; Hirano Y; Yoshiyasu T; So M; Matsui K
    J Infect Chemother; 2015 Jun; 21(6):438-43. PubMed ID: 25749360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
    Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
    J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis.
    Kohno S; Izumikawa K; Yoshida M; Takesue Y; Oka S; Kamei K; Miyazaki Y; Yoshinari T; Kartsonis NA; Niki Y
    Eur J Clin Microbiol Infect Dis; 2013 Mar; 32(3):387-97. PubMed ID: 23052987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report.
    Hanadate T; Wakasugi M; Sogabe K; Kobayashi T; Horita H; Kawamura I; Hori Y; Matsui K; Hoshino Y; Sou M
    J Infect Chemother; 2011 Oct; 17(5):622-32. PubMed ID: 21437682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: findings from a multicenter prospective observational study.
    Viscoli C; Bassetti M; Castagnola E; Cesaro S; Menichetti F; Ratto S; Tascini C; Giacobbe DR
    BMC Infect Dis; 2014 Dec; 14():725. PubMed ID: 25551699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why might micafungin be the drug of choice in pediatric patients?].
    Ramos Amador JT; Prieto Tato L; Guillén Martín S
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis.
    Benjamin DK; Deville JG; Azie N; Kovanda L; Roy M; Wu C; Arrieta A
    Pediatr Infect Dis J; 2013 Nov; 32(11):e419-25. PubMed ID: 23958810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of micafungin in pediatric immunocompromised patients with invasive fungal infection.
    Hashii Y; Kusuki S; Takizawa S; Tokimasa S; Ohta H; Hara J; Ozono K
    Pediatr Int; 2014 Dec; 56(6):834-837. PubMed ID: 24730676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of micafungin in pediatric clinical trials.
    Arrieta AC; Maddison P; Groll AH
    Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.
    Carter NJ; Keating GM
    Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease.
    Cornely OA; Marty FM; Stucker F; Pappas PG; Ullmann AJ
    Mycoses; 2011 Nov; 54(6):e838-47. PubMed ID: 21668522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
    Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
    Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Dose Micafungin for Preterm Neonates and Infants with Invasive and Central Nervous System Candidiasis.
    Auriti C; Falcone M; Ronchetti MP; Goffredo BM; Cairoli S; Crisafulli R; Piersigilli F; Corsetti T; Dotta A; Pai MP
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7333-7339. PubMed ID: 27697761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, efficacy, and safety of caspofungin in Japanese pediatric patients with invasive candidiasis and invasive aspergillosis.
    Mori M; Imaizumi M; Ishiwada N; Kaneko T; Goto H; Kato K; Hara J; Kosaka Y; Koike K; Kawamoto H; Maeda N; Yoshinari T; Kishino H; Takahashi K; Kawahara S; Kartsonis NA; Komada Y
    J Infect Chemother; 2015 Jun; 21(6):421-6. PubMed ID: 25701307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
    Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
    Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA; Scott LJ
    Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
    Ikeda F
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.